Blueprint Medicines Corp 4
4 · Blueprint Medicines Corp · Filed Feb 5, 2016
Insider Transaction Report
Form 4
Lengauer Christoph
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2016-02-03+40,000→ 178,179 totalExercise: $15.01Exp: 2026-02-03→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]This option vests with respect to 1/48th of the shares underlying the option on March 3, 2016 and as to an additional 1/48th of the shares underlying the option each month thereafter.